CONNECT BIOPHARMA HLDGS LTD's ticker is CNTB and the CUSIP is 207523101. A total of 30 filers reported holding CONNECT BIOPHARMA HLDGS LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $921,590 | -27.5% | 1,125,262 | 0.0% | 0.00% | – |
| Q2 2023 | $1,271,546 | +13.0% | 1,125,262 | 0.0% | 0.00% | – |
| Q1 2023 | $1,125,149 | +15.2% | 1,125,262 | 0.0% | 0.00% | – |
| Q4 2022 | $976,502 | -46.9% | 1,125,262 | -21.1% | 0.00% | – |
| Q3 2022 | $1,840,000 | +47.3% | 1,426,428 | -0.6% | 0.00% | – |
| Q2 2022 | $1,249,000 | -81.5% | 1,434,960 | -35.8% | 0.00% | – |
| Q1 2022 | $6,755,000 | -38.8% | 2,236,392 | +4.3% | 0.00% | – |
| Q4 2021 | $11,041,000 | -81.4% | 2,143,760 | -12.5% | 0.00% | -100.0% |
| Q3 2021 | $59,366,000 | +23.7% | 2,450,065 | -0.3% | 0.00% | +100.0% |
| Q2 2021 | $48,007,000 | +5.9% | 2,458,132 | +0.3% | 0.00% | 0.0% |
| Q1 2021 | $45,332,000 | – | 2,450,390 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 597,678 | $1,805,000 | 0.60% |
| RA Capital Management | 6,991,003 | $21,113,000 | 0.46% |
| Ikarian Capital, LLC | 677,859 | $2,047,000 | 0.27% |
| Kynam Capital Management, LP | 227,759 | $688,000 | 0.22% |
| Octagon Capital Advisors LP | 279,921 | $845,000 | 0.18% |
| RTW INVESTMENTS, LP | 446,564 | $1,349,000 | 0.03% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,437,500 | $4,341,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 77,851 | $235,000 | 0.01% |
| JANUS HENDERSON GROUP PLC | 1,599,826 | $4,807,000 | 0.00% |
| CSS LLC/IL | 20,000 | $60,000 | 0.00% |